Nadolol | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Nadolol
Canada

With Fermion, start the journey of your innovative API.

Contact Supplier

Suanfarma, at the Core of a Better Life.

Contact Supplier

pharmacompass-1-m-2026-03-23

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2026-03-23

Nadolol

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 5 USDMF, 2 CEP/COS, 1 JDMF, 3 EU WC, 5 NDC API, 9 Listed Suppliers, $ API Reference Price

15 API Suppliers
5 USDMF
2 CEP/COS
1 JDMF
3 EU WC
5 NDC API
9 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

66 FDF Dossiers, 52 FDA Orange Book, 4 Europe, 5 Canada, 2 South Africa, 3 Listed Dossiers

66 FDF Dossiers
52 FDA Orange Book
4 Europe
5 Canada
2 South Africa
3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 5MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 5MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 17 SPI Pharma, 5 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Kirsch Pharma, 1 Cerata Pharmaceuticals LLP, 2 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 15 BASF, 1 CD Formulation, 10 Corel Pharma Chem, 7 DFE Pharma, 7 Gangwal Chemicals, 4 Ideal Cures, 5 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

67 Fillers, Diluents & Binders, 38 Coating Systems & Additives, 37 Direct Compression, 31 Granulation, 29 Disintegrants & Superdisintegrants, 19 Taste Masking, 19 Controlled & Modified Release, 18 Chewable & Orodispersible Aids, 17 Thickeners and Stabilizers, 16 Lubricants & Glidants, 15 Co-Processed Excipients, 11 Solubilizers, 8 Parenteral, 6 API Stability Enhancers, 5 Film Formers & Plasticizers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Emulsifying Agents, 3 Rheology Modifiers, 2 Coloring Agents, 1 Surfactant & Foaming Agents, 1 Topical

67 Fillers, Diluents & Binders
38 Coating Systems & Additives
37 Direct Compression
31 Granulation
29 Disintegrants & Superdisintegrants
19 Taste Masking
19 Controlled & Modified Release
18 Chewable & Orodispersible Aids
17 Thickeners and Stabilizers
16 Lubricants & Glidants
15 Co-Processed Excipients
11 Solubilizers
8 Parenteral
6 API Stability Enhancers
5 Film Formers & Plasticizers
5 Empty Capsules
4 Vegetarian Capsules
4 Emulsifying Agents
3 Rheology Modifiers
2 Coloring Agents
1 Surfactant & Foaming Agents
1 Topical

DIGITAL CONTENT

9 News #PharmaBuzz

9 News #PharmaBuzz

GLOBAL SALES INFORMATION

15 US Medicaid Prescriptions, 17 Regulatory FDF Prices

15 US Medicaid Prescriptions
17 Regulatory FDF Prices

MARKET PLACE

1 APIs

1 APIs

REF. STANDARDS & IMPURITIES

2 EDQM, 2 Others

2 EDQM
2 Others

$ API Ref.Price (USD/KG) : 839 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

5 All

01 3APOTEX INC

02 2MINT PHARMACEUTICALS INC

filter Active Ingredients Reset all filters

5 All

01 5NADOLOL

filter Dosage Form Reset all filters

5 All

01 5TABLET

filter Brand Name Reset all filters

5 All

01 3APO-NADOLOL

02 2MINT-NADOLOL

List of Suppliers

Product Main Page

01

APOTEX INC

CGT Asia

Not Confirmed

APOTEX INC

CGT Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Brand Name : APO-NADOLOL

Dosage Form : TABLET

Dosage Strength : 80MG

Packaging : 100

Approval Date :

Application Number : 782467

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

APOTEX INC

CGT Asia

Not Confirmed

APOTEX INC

CGT Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Brand Name : APO-NADOLOL

Dosage Form : TABLET

Dosage Strength : 160MG

Packaging : 100

Approval Date :

Application Number : 782475

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

APOTEX INC

CGT Asia

Not Confirmed

APOTEX INC

CGT Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Brand Name : APO-NADOLOL

Dosage Form : TABLET

Dosage Strength : 40MG

Packaging : 100

Approval Date :

Application Number : 782505

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

MINT PHARMACEUTICALS INC

CGT Asia

Not Confirmed

MINT PHARMACEUTICALS INC

CGT Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Brand Name : MINT-NADOLOL

Dosage Form : TABLET

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number : 2496380

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

MINT PHARMACEUTICALS INC

CGT Asia

Not Confirmed

MINT PHARMACEUTICALS INC

CGT Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Brand Name : MINT-NADOLOL

Dosage Form : TABLET

Dosage Strength : 80MG

Packaging :

Approval Date :

Application Number : 2496399

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.